Status:
RECRUITING
Role of Specific microRNAs in Cluster Headache
Lead Sponsor:
IRCCS National Neurological Institute "C. Mondino" Foundation
Conditions:
Cluster Headache
Eligibility:
All Genders
18-65 years
Brief Summary
Cluster headache (CH) is a primary headache included in the trigeminal autonomic cephalalgias (TACs) according to the International Calssification of Headache Disorder, Third Edition. CH is characteri...
Detailed Description
Background Cluster headache (CH) is a primary headache included in the trigeminal autonomic cephalalgias (TACs) according to the International Calssification of Headache Disorder, Third Edition. CH is...
Eligibility Criteria
Inclusion
- \- Healthy Controls
- age between \>18 and \<65 years
Exclusion
- diagnosis of primary and/or secondary headache according to ICHD-III criteria (only diagnosis of sporadic tension type headache is allowed)
- diagnosis of neurological disorders
- diagnosis of medical conditions considered clinically relevant by the researcher
- pregnant and lactating women
- taking NSAIDs, triptans or opiates in the previous 24 hours
- Episodic Cluster Headache
- Inclusion Criteria:
- diagnosis of Episodic Cluster Headache according to ICHD-III criteria (at least 1 year at screening)
- age between \>18 and \<65 years of both genders
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06503328
Start Date
March 1 2023
End Date
June 30 2025
Last Update
July 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Mondino Foundation
Pavia, Italy, 27100